Related references
Note: Only part of the references are listed.Acute neurofunctional effects of escitalopram during emotional processing in pediatric anxiety: a double-blind, placebo-controlled trial
Lu Lu et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Research Review: Pediatric anxiety disorders - what have we learnt in the last 10 years?
Jeffrey R. Strawn et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2021)
CYP2C19 METABOLIZER STATUS PREDICTS ESCITALOPRAM PHARMACOKINETICS IN CHILDREN AND ADOLESCENTS
Sam Vaughn et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2021)
Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial
Lu Lu et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2021)
Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial
Jeffrey R. Strawn et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
Jeffrey R. Strawn et al.
FRONTIERS IN PHARMACOLOGY (2021)
Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysis
Jeffrey A. Mills et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2020)
Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study
Jeffrey R. Strawn et al.
JOURNAL OF CLINICAL PSYCHIATRY (2020)
CYP2C19-Guided Escitalopram and Sertraline Dosing in Pediatric Patients: A Pharmacokinetic Modeling Study
Jeffrey R. Strawn et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2019)
Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
Stacey L. Aldrich et al.
FRONTIERS IN PHARMACOLOGY (2019)
Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis
Eric T. Dobson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2019)
The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis
Jeffrey R. Strawn et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2018)
Sociodemographic, clinical, and functional long-term outcomes in adolescents and young adults with mental disorders
E. Asselmann et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study
Jeffrey R. Strawn et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2017)
Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents A Systematic Review and Meta-analysis
Cosima Locher et al.
JAMA PSYCHIATRY (2017)
A Randomized, Placebo-Controlled Study of Duloxetine for the Treatment of Children and Adolescents With Generalized Anxiety Disorder
Jeffrey R. Strawn et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2015)
Somatic Complaints in Anxious Youth
Sarah A. Crawley et al.
CHILD PSYCHIATRY & HUMAN DEVELOPMENT (2014)
Predictors and Moderators of Treatment Response in Childhood Anxiety Disorders: Results From the CAMS Trial
Scott N. Compton et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2014)
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
J. K. Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Defining Treatment Response and Remission in Child Anxiety: Signal Detection Analysis Using the Pediatric Anxiety Rating Scale
Nicole E. Caporino et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2013)
Twelve-Month Suicidal Symptoms and Use of Services Among Adolescents: Results From the National Comorbidity Survey
Mathilde M. Husky et al.
PSYCHIATRIC SERVICES (2012)
Suicidal Ideation in Anxiety-Disordered Youth
Kelly A. O'Neil et al.
SUICIDE AND LIFE-THREATENING BEHAVIOR (2012)
The Columbia-Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
Kelly Posner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
The role of mental disorders in the risk and speed of transition to alcohol use disorders among community youth
S. Behrendt et al.
PSYCHOLOGICAL MEDICINE (2011)
Incidence and Risk Patterns of Anxiety and Depressive Disorders and Categorization of Generalized Anxiety Disorder
Katja Beesdo et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Burden of Anxiety Disorders in Pediatric Medical Settings
Holly J. Ramsawh et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2010)
Reliability and Validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
David V. Sheehan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety
John T. Walkup et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
What do childhood anxiety disorders predict?
Antje Bittner et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2007)
Proximal psychiatric risk factors for suicidality in youth - The Great Smoky Mountains Study
Debra L. Foley et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder
MA Rynn et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Fluvoxamine for the treatment of anxiety disorders in children and adolescents
JT Walkup et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
